充血性心力衰竭患者血清IL-1β变化及胺碘酮对PBMC分泌IL-1β的影响

下载PDF

导出

作者姚恒臣冯桂芹孔祥泉张颖新王英丽高航侯新华侯岩芳

机构地区聊城市人民医院

出处《山东医药》 CAS 北大核心 2000年第23期28-29,共2页 Shandong Medical Journal

基金山东省99科技攻关项目!(NO.9912 0 5 914 )

关键词充血性心力衰竭 IL-1Β 胺碘酮 PBMC

参考文献6

1Packer M.Sudden unexpected death in patients with congestive heart failure:a second frontier.Circulation,1985,72:681.
2Bigger JT.Why patients with congestive heart failure die:arrythmias and sudden cardiac death.Circulation,1987,75:28.
3Cleland JGF,Dargie HJ,Findly IN,et al.Clinical,haemodynamic,and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.Br Heart J,1987,57:436.
4Shioi T,Matsumori A,Kiharaa Y,et al.Increased expression of interleukin-1β and monocyte chemotactic and activiting factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload.Cir Res,1997,81:664.
5Matsumori A,Ono K,Nishio R,et al.Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells,Circulation,1997,96:1386.
6Doyama K,Fujigara H,Fukumoto M,et al.Tumor necrosis factor-alpha expression in cardiac tissue of patients with heart failure.Int J Cardiol,1996,54:217.

山东医药

2000年第23期

内容加载中请稍等...